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Abstract Mothers living with HIV (MLH) are at high
risk for acute and chronic stress, given challenges related to
their HIV status, ethnicity, economic and urban living
conditions. Biomarkers combined into a composite index
show promise in quantifying psychosocial stress in healthy
people, but have not yet been examined among MLH.
According, we examined potential biomarker correlates of
stress [cortisol and catecholamines from home-collected
urine and basic health indicators (blood pressure, height
and weight, waist-to-hip ratio) measured during an inter-
view] among 100 poor African American and Latina
mothers MLH and demographic-matched control mothers
without HIV (n = 50). Participants had been enrolled in a
randomized controlled trial about 18 months earlier and
had either received (MLH-I) or were awaiting (MLH-W)
the psychosocial intervention. Participation was high, bio-
markers were correctly collected for 93% of cases, and a
complete composite biomarker index (CBI) calculated for
133 mothers (mean age = 42). As predicted, MLH had a
signiﬁcantly higher CBI than controls, but there was no
CBI difference across ethnicity or intervention group. CBI
predicted CD4 counts independently after controlling for
age, years since diagnosis, prior CD4 counts, medication
adherence, and depression symptoms. The study demon-
strates acceptability, feasibility and potential utility of
community-based biomarker collections in evaluating
individual differences in psychosocial stress.
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Introduction
Psychosocial stress correlates strongly with mental health
symptoms, risky health practices and lifestyles (e.g., sub-
stance use, unprotected sex, poor medication adherence,
sleep, diet, physical activity) and compromised physio-
logical function—all factors that lead to increased risk for
opportunistic infection and rapid HIV disease progression.
With mapping of the human genome and technological
advances in biological measurement, there is increased
interest in the use of non-invasive biomarkers to quantify
psychosocial stress. As articulated by Kraemer et al.
(2002), biomarkers may be sought in order to (1) more
accurately or precisely measure an event or process; (2)
measure an event or process earlier in time, when the
information may improve prevention and intervention
opportunities; and (3) provide insights into the cause,
prevention, course and treatment of a disorder that the
diagnosis itself would not reveal (pp. 655). Studies among
primarily healthy (and HIV negative) groups have shown
success in using stress-inﬂuenced biomarkers to predict
later physical and cognitive decline (Seeman et al. 2008),
reﬂect the presence and severity of mental health symp-
toms (Glover and Stuber 2006) and estimate the size of the
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and chronic stress (Glover et al. 2008).
Within the HIV research community, there is consensus
that biological indicators can serve as mediators and
moderators in precipitating symptoms of anxiety and
depression, can inﬂuence immune system functioning, and
may also alter the severity and progression of the disease
(Kopinsky et al. 2004). Emerging studies of speciﬁc bio-
markers in HIV? samples conﬁrm the relevance of stress-
inﬂuenced biomarkers in basic molecular mechanisms of
HIVAIDS (Kopinsky et al. 2004; Kumar et al. 2003;
Sherman et al. 2004). For example, norepinephrine (NE), a
neurotransmitter of the autonomic nervous system (ANS)
released in response to stress, has been shown to accelerate
HIV-replication (Cole et al. 1998, 2003; Cole 2008). Novel
interventions focusing on altering ANS activity generally,
or NE speciﬁcally, may delay the development of clinical
disease. Concurrently, promoting stress management
among HIV? persons has shown that reducing general
distress, anxiety, and depression may alter immune and
endocrine biomarkers among Caucasian men, as well as
progression of HIV (Antoni 2003; Leserman 2003; McCain
et al. 2003; Sherman et al. 2004).
Interventions that reduce psychological distress among
HIV? persons do not inﬂuence biological markers or do so
inconsistently (Brown and Vanable 2008; Crepaz et al.
2008; Scott-Sheldon et al. 2008). The negative ﬁndings
have been attributed to socio-demographic factors (age,
gender, race/ethnicity), assessment timing (shortly after the
intervention vs. months later), and analytic complexities of
disease variables which themselves are known to be asso-
ciated with dysregulated mood, cognition, and somatic and
neurovegetative symptoms (stage of HIV, time since
infection, medications). Biological systems are further
inﬂuenced by health behaviors (sleep, diet, and level of
physical activity), hormonal cycles (menses and meno-
pause) and licit and illicit substances (tobacco, alcohol and
drugs) (Chander et al. 2006; Kudielka and Kirschbaum
2005; Kirschbaum et al. 1999). Existing biomarker studies
in HIV have sometimes been limited by incomplete
attention to such potential mediators and moderators
(Arendt 2006; Boarts et al. 2006; Kopinsky et al. 2004).
The selection of biomarker outcomes may also con-
tribute to weak or equivocal biomarker effects in HIV
intervention studies. Psychoneuroimmunological research
typically requires drawing blood and processing samples
on the same day with sophisticated assay techniques. The
cost and practical barriers of this approach in community-
based research not only reduces the amount of research
possible, but may also limit participation due to high
subject burden. Also, most studies to date have focused on
one or two systems/biomarkers—for example, a disease
speciﬁc immune system indicator (CD4 counts), the ANS
(norepinephrine) or the hypothalamic-pituitary-adrenal
(HPA) axis (cortisol). These biomarkers are often exam-
ined in isolation, precluding a comprehensive
understanding of interactions within and across biomarkers
and systems.
An alternative approach is one ﬁrst used within the
context of epidemiological studies of healthy aging, based
on the allostatic load (AL) model (McEwen 2004; McE-
wen and Seeman 1999; McEwen and Wingﬁeld 2003).
Brieﬂy, the model describes the normal biological response
to a stress perturbation as a series of adaptive changes in
multiple systems designed to meet the challenge and then
return to physiological stability or allostasis. Successful
adaptation to stress is operationalized as the ability to
maintain homeostasis in the face of internal and external
perturbations. AL represents the cumulative price the body
pays for adapting to repeated adverse psychosocial, phys-
ical, and environmental challenges. It is the inability to
achieve and maintain allostasis that is thought to serve as
the basis for long-term negative physical health conse-
quences of stress. This framework uses a set of biomarkers
combined into a composite index to quantify cumulative
stress exposure.
A composite biomarker index of AL reﬂecting cardio-
vascular activity, atherosclerosis development, HPA axis
functioning, glucose metabolism, and sympathetic nervous
system (SNS) activation has been shown to predict cog-
nitive and physical functioning, cardiovascular disease, and
mortality in healthy elderly samples (Karlamangla et al.
2002; Seeman et al. 2001). The index also increases with
age (Crimmins et al. 2003), is differentially higher among
African American women across all ages (Geronimus et al.
2006), and is associated with posttraumatic stress symp-
toms (PSS) in mothers of children with a serious illness
(Glover and Stuber 2006). In a study of illness-precipitated
PSS among mothers of children with cancer, the index has
been shown to discriminate between groups in a ‘‘dose-
response’’ manner (highest to lowest: PSS-symptomatic
cancer mothers, non-symptomatic but chronically stressed
cancer mothers, control mothers of healthy children), even
when individual biomarkers do not (Glover and Stuber
2006). Recently, a high biomarker composite index was
linked to smaller hippocampal volume in mothers of seri-
ously ill children (Glover et al. 2008).
The composite biomarker approach offers several
potential advantages for biomarker research among indi-
viduals with HIV. First, the biomarkers typically collected
are non-invasive and relatively inexpensive, comprised
from home-collected urine (cortisol and catecholamines),
saliva (cortisol, DHEA), and brief general health measures
familiar to participants (blood pressure, heart rate, height
and weight). Second, the biomarkers represent multiple
biological systems that can be analyzed individually,
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across systems. Third, the approach uses relative risk
composite scores that may be better predictors of poor
health outcomes than levels of individual biomarkers that
fall into a ‘‘clinical’’ range for pathology (Glover and
Stuber 2006; Glover et al. 2008; Kopinsky et al. 2004).
Composites inherently select ‘‘extreme’’ scorers, thereby
supporting comparisons of individuals at greatest risk and
those displaying the greatest ‘‘resilience’’ to HIV? stress.
Composite risk scores appear to offer maximal sensitivity
to potentially small-to-moderate effects as might be seen in
community-based intervention samples.
On the other hand, composite risk scoring methods to
date are based on a primary assumption that is increasingly
questioned for population studies and may be especially
unlikely to hold true in HIV? samples. Speciﬁcally,
scoring confers a risk ‘‘point’’ for each biomarker in the top
quartile of the sample distribution and the direction of risk
is assumed to be unidirectional. Thus, high levels of pri-
mary neuroendocrine mediators (cortisol and
catecholamines) as well as secondary cardiovascular
(blood pressure, heart rate) and metabolic (body mass
index, waist to hip ratio) outcomes are assumed to be
reﬂective of risk. There is now substantial evidence for
bidirectional risk (too high or too low) in primary media-
tors. For example, despite extensive data showing
detrimental health effects of high cortisol, numerous
studies have now shown low cortisol in PSS samples
(Glover and Stuber 2006; Yehuda et al. 1996) and in
elderly individuals with high depression, perceived stress,
and physical complaints (Hellhammer et al. 2004).
Equivocal directionality of other primary neuroendocrine
biomarkers and secondary outcomes is cited as the ratio-
nale for scoring all biomarkers with bidirectional risk (Glei
et al. 2007; Seplaki et al. 2005). Such a strategy seems
warranted in HIV? samples, where PSS symptoms may be
prevalent (Gaynes et al. 2008; Israelski et al. 2007; Myers
et al. 2006; Whetten et al. 2006, 2008) and lipodystrophy
or other metabolic disturbances are known sequelae of
HIV? infection, antiviral medications, or both (Chang
et al. 2007).
To our knowledge, a composite biomarker index has
never been reported for HIV? samples. Accordingly, in
this study we examine a bi-directional biomarker risk
composite in relation to effects of ethnicity (African
American and Latina) and HIV status (HIV? or HIV-)
among low-income minority women at high risk for psy-
chological stress. Women of racial and ethnic minority
backgrounds are the fastest growing proportion of new
AIDS diagnoses in the United States. According to recent
numbers from the Centers for Disease Control and Pre-
vention [CDC] (2009), African American and Latina
women represent 82% of the total estimated AIDS
diagnoses. AIDS is the leading cause of death among
African American (AA) women ages 25–34. For Latinas
(LA), AIDS is the fourth leading cause of death among
women 35–44. Our sample is a subset recruited from a
larger intervention study for mothers living with HIV
(MLH) and their children (described by Rotheram-Borus
et al. 2001). The sample consists of MLH who received a
psychosocial intervention (MLH-I) and those awaiting the
intervention (MLH-W).
A necessary step in examining the potential utility of
stress-related biomarker composites in HIV-related inter-
vention research is to establish acceptability (participation)
and feasibility (accurate completion of collection protocols
within low-resource settings). If these aims are met, our
additional goal is to investigate the utility of a biomarker
composite to differentiate groups on the basis of HIV
(MLH vs. controls), ethnicity (AA vs. LA) or intervention
status (MLH-I vs. MLH-W). Reﬂecting the burden of HIV
on mental and physical health outcomes, we predict MLH
groups will show higher biological risk scores than HIV-
control mothers. We make no predictions for ethnicity, but
sample for an equal number of AA and LA women in each
group to examine possible ethnicity effects. Finally, we
predict that MLH-I will show lower biological risk scores
than MLH-W awaiting the intervention. Analyses of the
larger dataset to date show no effect of the intervention on
mother self-report psychosocial stress measures, perhaps
because baseline MLH scores indicate relatively low psy-
chological distress (S. Comulada, personal communication,
March 3, 2009). Nonetheless, biological risk scores may be
more sensitive to group effects than self-report measures.
Methods
Participants
MLH were recruited from a larger parent study of a family-
based HIV prevention and coping intervention in Los
Angeles County (Rotheram-Borus et al. 2001). From Jan-
uary 2005 to October 2006, 342 women living with HIV?
who were living in poverty and the mother/primary female
caregiver of a child between the ages of 6 and 20 years old
were recruited from HIV clinics, health clinics, women’s
support group and advertising (refusal rate = 12.5%).
Concurrently, 205 HIV- mothers were recruited from
public venues (e.g., outside grocery stores) in the same
neighborhoods where MLH lived. HIV- mothers were
matched to MLH based on race/ethnicity, age of children,
and neighborhood of residence. All mothers received a full
battery of standardized measures of psychological and
physical health at 6 month intervals. Most families lived
below the poverty line ($20,000) (86% of MLH and 66% of
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of mothers and were not the source of HIV infection. MLH
were randomly assigned to an immediate intervention
(MLH-I) or wait list (MLH-W) which offered the inter-
vention at a later time. The basic eight-session intervention
focused on coping with HIV and being a parent. Up to 8
additional booster sessions were also offered for a total of
16 possible intervention sessions.
A subset of MLH (n = 100) and controls (n = 50) from
this larger cohort were recruited for the biomarker assess-
ment and MLH were composed of 50 each of MLH-I and
MLH-W. Recruitment aimed for an equal number of
African American and Latina women in each group to
allow for ethnic comparisons as recommended (Scott-
Sheldon et al. 2008). Biomarker assessment was timed to
coincide with the ongoing 18 or 24-month follow-up
interviews of the parent study. The biomarker project was
explained and offered as a separate study to each consec-
utive MLH and control scheduled for a follow-up interview
until the sample goal of N = 150 was met.
Measures
The biomarker index was created from home-collected
urine (cortisol and catecholamines) and standard health
measures (blood pressure, heart rate, height and weight)
(see Table 1.) Urinary indicators were collected at home by
participants during a 12-h overnight collection period
designed to represent ‘‘resting’’ hormone values. Standard
health measures were recorded during a scheduled inter-
view conducted within a few days of the urine collection.
Heart rate and systolic and diastolic blood pressure were
measured using an automatic inﬂation digital device
meeting the Association for Advancement of Medical
Instrumentation (AAMI) standards and with appropriate
cuff size, following standard protocol (Pickering 1996).
Supplies for urine collection (a urine specimen container,
toilet ‘‘hat’’ and cooler) were provided.
Urine was collected in a container with a preservative
(0.3 g of sodium metabisulﬁte). Samples were kept cool in
an ‘‘igloo’’ container until transport to the laboratory. After
evaluation of total urine volume, aliquots were frozen at
-80C until analyzed via EIA and Enzyme Immunoassay
for the quantitative determination of endocrine concentra-
tion (cortisol and catecholamines). Safeguards for assuring
compliance to urine collection procedures include mea-
suring the volume of urine, the amount of creatinine per
total volume, and the concentration of each biomarker in
total and as a function of the creatinine level. There are
reference ranges for each of these measurements that allow
for identiﬁcation of potentially contaminated samples,
which were discarded according to universal precautions.
Risk was calculated as bi-directional, as recommended
(Glei et al. 2007; Seplaki et al. 2005). The biomarker index
was calculated by assigning one risk ‘‘point’’ for each
biomarker falling in the bottom (15th percentile) or top
(85th percentile) of the total sample distribution and then
summing the risk points. Each participant could therefore
score between zero and nine, reﬂecting the total possible
number of biomarkers in a ‘‘high-risk’’ range (either very
high or very low).
Existing data on sociodemographics, health status, and
medication usage in HIV? mothers were collected from
the parent study. New instruments for the biomarker sup-
plement consisted of three brief instruments. The Health
Behaviors Questionnaire (HBQ) is a short self-report
questionnaire to assess activities in the 24 h prior to bio-
marker collection. Questions monitor caffeine drinks,
cigarettes, alcoholic beverages (number of), aerobic and
anaerobic exercise (minutes and quality), sleep (hours and
quality), meals (number and timing), prescribed and rec-
reational medication (type and amount), and illness
symptoms (fever, cold, ﬂu, headache, etc.). Information
from the HBQ was used to exclude urine samples that may
be contaminated by known confounders and to identify
potential associations with the biomarker index. The
Table 1 Summary of biomarkers
Procedures
Diastolic BP (mm Hg) Average of second and third of 3 seated readings at rest and after habituation to environment
Systolic BP (mm Hg)
Heart rate (bpm)
Waist to hip ratio Waist circumference measured at its narrowest point between the ribs and iliac crest and hip
circumference measured at the maximal buttocks
Body mass index 703 9 [Weight in pounds/height
2] Am Heart and Lung Institute
Norepinephrine (lg/12 h) Assayed from 12-h overnight urine collection. Calculated as total concentration in 12-h urine
volume and as portion per creatinine level (See Glover and Poland 2002) Epinephrine (lg/12 h)
Dopamine (lg/12 h)
Cortisol (lg/12 h)
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DSM-IV criteria to evaluate Criterion A traumatic expo-
sure history and symptom clusters of re-experiencing,
avoidance/numbing, and hyperarousal. The PSS is a com-
mon research instrument that compares well to clinician
ratings obtained in structured interviews. The Beck
Depression Inventory (BDI) is a 21-item self-report ques-
tionnaire widely used to assess symptoms of depression
(Beck et al. 1988). All instruments were completed in the
language preferred by the participant (English or Spanish).
Procedures
All participants of the intervention study who were about to
be scheduled for their regular follow-up interviews were
informed of the biomarker pilot and asked to participate.
Recruitment continued until the total sample (balanced for
ethnicity) was consented. For those consenting, existing
staff then conducted a brief interview, collected partial
biomarker data (diastolic and systolic blood pressure,
height and weight, and hip to waist ratio) and gave
instructions and supplies needed for the 12-h urine col-
lection and a later saliva collection. The interview also
included administration of the PSS and BDI. (Results from
home-collected saliva assayed for cortisol and DHEA-S are
reported elsewhere: Glover et al. 2009). This study was
approved by the UCLA Institutional Review Board.
Participants were instructed to begin to collect urine
near bedtime and end urine collection right after their
customary waking time (including the ﬁrst morning void)
so as to collect all voids within a 12 h period. Instructions
for urine sample included (1) avoiding contaminants in
urine (rescheduling collection if menstruating or sexual
intercourse occurred during the collection); (2) reschedul-
ing if transitory illness occurred (cold/ﬂu); (3) abstaining
from substance use (other than prescribed medications).
The HBQ was reviewed in advance to inform participants
of what could unduly inﬂuence urine collection and impede
correct interpretation of assays. Participants completed the
HBQ after biomarker collection and data were reviewed for
veriﬁcation and to analyze the potential impact of speciﬁc
behaviors on the biomarker index. Participants were asked
to refrain from non-prescribed substance use (alcohol and
drugs) for 24 h prior to biological sample collection and to
re-schedule the collection if they were feeling ill, if they
had an unusual or atypical day, etc. We explained that the
biomarkers are used to assess their own overall health and
that the accuracy of the measurement depends on their
ability to follow instructions in collection and procedures.
They were encouraged to remain on their prescribed
medications (including HIV medications) as directed by
their physicians.
Statistical Analysis
Percentiles for speciﬁc biomarker indicators were identi-
ﬁed and one risk point assigned for each indicator falling in
the range of risk (highest or lowest for the total sample).
Risk points were summed and frequency of risk for each
biomarker as a function of group was calculated. The ﬁnal
composite index was examined for normality and with
Levine tests to examine violations in homogeneity of var-
iance before conducting Analysis of Covariance
(ANCOVA). ANCOVA procedures were also used to
compare raw values of each indicator across groups after
controlling for age. Linear regression methods were used to
examine the predictive value of the composite for most
recent CD4 counts.
Results
Acceptability and Feasibility
Only three potential participants from the larger cohort
refused the present study. Complete biomarker collections
and interviews were conducted with a total of 147 partic-
ipants. Of these, eight (MLH = 4, Controls = 4), were
discarded due to urine volumes or creatinine levels indic-
ative of error in collection (volume lower than expected or
creatinine values out of the normative range). Three more
cases were incomplete, with two missing systolic and
diastolic blood pressure due to a mechanical failure of the
machine and one with an undetectable level of norepi-
nephrine in urine. Biomarkers were correctly collected for
136 (93% of the total). Self-reported recreational drug use
was rare in this sample. Six participants reported marijuana
use within 24 h of biomarker collection (2 AA controls, 3
AA MLH-W and 1 Latina MLH-I). Repeating analyses
without these cases did not alter the biomarker index
ﬁndings. One participant reported use of crack cocaine and
two reported more than three alcoholic drinks during the
period. These three cases were dropped from analysis. The
ﬁnal sample (N = 133) consisted of Controls (n = 44) and
MLH (n = 89).
Health Behaviors
Groups did not differ on number of caffeinated (M = 1.45,
SD = 1.8) or alcoholic drinks (M = 0.09, SD = 0.4),
cigarettes (M = 2.21, SD = 5.3), minutes of aerobic
(M = 7.37, SD = 24.9) or anaerobic (M = 21.60
SD = 41.4) exercise or hours of sleep on the night of urine
collection (M = 7.04, SD = 2.1). None of these variables
were related to the biomarker composite.
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Overall, MLH and controls did not signiﬁcantly differ on
age, ethnicity, education, or number of persons living in the
home. Signiﬁcantly more control mothers (46.3%) reported
having a job than MLH (27.9%), and reported greater
monthly income (Controls: M = $1,615, SD = $1,500,
range = $168–9,000) than MLH (M = $990, SD = $730,
range = 0–$9,000). Both groups reported they were
struggling or barely able to pay their bills (Controls:
57.5%; MLH: 47.8%) relative to those reporting they were
‘‘doing ok’’ ﬁnancially. The ﬁnal sample had slightly more
LA (53.3%) than AA (46.7%) mothers. Age was not sig-
niﬁcantly different by group or ethnicity, but a signiﬁcant
group X ethnicity interaction [F(1, 133) = 4.83, P\.05]
indicated no ethnic differences in age among controls
(M = 42.61, SD = 8.26), but older age among AA MLH
(M = 45.14 SD = 7.9) than among LA MLH (M = 40.38,
SD = 7.9). Education differed by ethnicity [X
2 (1,
N = 134) = 25.53, P\.01]; 76.4% of LA vs. 33.9% of
AA reported less than a high school education. Also, LA
mothers reported signiﬁcantly more adults living in the
home (M = 2.11, SD = 1.1) than AA mothers (M = 1.63,
SD = 1.0), but the groups did not differ on the reported
number of children at home (M = 2.87, SD = 1.7). Most
LA mothers (83.6%) participated in assessments in Spanish
(and conducted by Spanish-speaking interviewers). The
biomarker composite was not associated with education,
number of adults or children in the home or primary
language.
HIV Variables
Among MLH, 97% of self-reports of CD4 cells were over
200 in 97% (M = 576.93, SD = 212.3, range 0–1,400) and
87% reported undetectable viral loads. There were 66.3%
(n = 61) who reported on antiviral medication adherence.
Of these, 70.5% (n = 43) reported 100% medication
adherence in the last 3 days, and the remaining 29.5%
(n = 18) admitted skipping medications on one or more of
the past 3 days. Viral load, CD4 cell count, and medication
adherence were not signiﬁcantly different as a function of
ethnicity or intervention status. MLH reported learning of
their HIV status from 2 to 25 years ago (M = 11.57,
SD = 5.0) with two cases reporting ‘‘do not know’’. AA
MLH had known their HIV status longer than LA MLH.
The biomarker composite was not signiﬁcantly correlated
with time since infection, viral load or baseline CD4
counts, but was negatively correlated with most recent CD4
counts (Pearson r =- .26, P\.05). All biomarker com-
posite analyses included age, and intervention analyses
(excluding controls) also included years since HIV
diagnosis.
Intervention Participation (MLH-I Only)
Of 48 MLH-I offered the psychosocial intervention 6
(12.5%) did not complete any sessions (4 AA MLH and 2
LA MLH). Of the remaining 42 (87.5%), the mean number
of sessions attended was 18.1 (SD = 5.7), with a range of
9–36. The number of sessions attended was not signiﬁ-
cantly related to any socio-demographic, health behavior,
HIV or psychological variables or the biomarker composite
itself.
Psychological Variables
ANOVA indicated a signiﬁcant group effect for BDI scores
[F(2, 131) = 3.62, P\.05] and planned contrasts indi-
cated MLH-I (M = 12.42, SE = 1.4) and MLH-L
(M = 13.57, SE = 1.5) reported signiﬁcantly more
depression than controls (M = 8.14, SE = 1.5). BSI global
severity scores did not show a signiﬁcant group effect.
There was no evidence of ethnicity differences in depres-
sion or global distress. On the PSS, 37 participants said
they had never experienced any of the potentially traumatic
events listed, and another 23 who reported having at least
one trauma exposure said the event did not bother them.
Thus, there were 60 ‘‘non-responders’’ and 74 responders
(who said they had experienced at least one traumatic event
that bothered them and answered questions about symp-
toms). Non-responders were disproportionally control
mothers (31 of 60); 70% of all controls but only 32% of
MLH were non-responders. Among MLH, non-responders
were signiﬁcantly more depressed than responders and 12
of 61 MLH with both BDI and PSS scores met criteria for
clinically relevant levels of both depression (BDI[16)
and PTSD (PSS[18) symptoms. PSS scores were unre-
lated to the biomarker composite. The composite index was
signiﬁcantly associated with depression (r = .29, P\.05)
and BSI global severity of distress (r = .34, P\.05) for
controls, but not for MLH (r\.20). Among MLH, none of
the subscales of the BSI correlated with the composite
index.
Individual Biomarkers
As seen in Table 2, raw values for each of the biomarkers
indicated no effect of group (control vs. MLH) or inter-
vention (MLH-I vs. MLH-W). Signiﬁcant ethnicity
differences emerged for urinary cortisol and catechola-
mines and cardiovascular variables (blood pressure, heart
rate). Among controls and MLH, AA mothers were ele-
vated relative to LA mothers on all cardiovascular
variables (systolic and diastolic blood pressure and resting
heart rate: P\.01). Cortisol was elevated in LA versus
AA control mothers [F(1, 44) = 10.76, P\.01]. Among
344 AIDS Behav (2010) 14:339–350
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mothers [F(1, 89) = 6.26, P\.01], whereas LA mothers
showed signiﬁcantly higher epinephrine [F(1, 44) = 4.77,
P\.05]. Chi-square analyses of bi-directional risk points
(yes/no) for each biomarker indicated no signiﬁcant group,
intervention or ethnicity effects (not shown).
Composite Biomarker Index
As predicted, the ANCOVA indicated MLH had signiﬁ-
cantly higher biomarker composites (M = 2.54, SD = 1.4)
than controls (M = 1.75, SD = 1.3) [F(1, 133) = 8.22,
P\.001] and no ethnicity or group X ethnicity interac-
tion. See Table 3 for the raw biomarker composite scores
for all participants as a function of group and ethnicity.
To examine an intervention effect (MLH-I vs. MLH-W)
in the biomarker composite, covariates added to the
ANCOVA included: age, time since HIV infection, base-
line CD4 counts, medication adherence (last 3 days yes/
no) and number of intervention sessions attended (analyzed
by removal of the MLH-I with 0 attendance and by
retaining them but including sessions attended as a
covariate (coding MLH-W as 0 attendance). There was no
signiﬁcant intervention effect and medication adherence
was the only signiﬁcant covariate (P\.04). A separate
ANOVA indicated those MLH who reported adherence
over the past 3 days had higher composite scores
(M = 2.65, SD = 1.4) than non-adherent MLH
(M = 1.90, SD = 1.37). Medication adherent MLH also
reported lower CD4 counts, suggesting adherent MLH may
be more ill than non-adherent MLH.
To determine if the biomarker composite provided fur-
ther predictive value for most recent CD4 counts after
controlling for other known predictors, a linear regression
model was developed. Age, baseline CD4, medication
adherence, psychological variables and group intervention
status were entered ﬁrst, followed by the biomarker com-
posite. The PSS, BSI and group intervention status were
not signiﬁcant predictors and were dropped. As shown in
Table 4, the overall model signiﬁcantly predicts most
recent CD4 counts, R
2 = .53, R
2 adjusted = .49, F(6,
85) = 14.69, P\.001. Three of the seven predictor vari-
ables signiﬁcantly contributed to the model: (1) baseline
CD4 counts; (2) depression symptoms and (3) the bio-
marker composite. Baseline CD4 counts were positively
associated with current CD4 levels, whereas both depres-
sion symptoms and the biomarker composite were
negatively associated with current CD4 (as depression and
biomarker composite scores increased, CD4 levels
decreased).
To determine if the model was equally predictive for
AA and LA mothers, the regression model was repeated
separately for each ethnicity. The overall model remained
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123signiﬁcant for AA F(6, 39) = 6.45, P\.001 and for LA
F(6, 45) = 15.16, P\.001, but differences based on eth-
nicity emerged in several variables. First, baseline CD4
levels and the biomarker composite remained signiﬁcant
predictors of current CD4 for AA and LA, but depression
scores were only predictive for LA mothers. Second, the
t-values for years since diagnosis were in opposite direc-
tions, although not signiﬁcant for either ethnicity. This may
reﬂect differential HIV infection progression as a function
of ethnicity. Finally, the variance explained for LA was
higher (R
2 = .65) than for AA (R
2 = .46).
Discussion
This ﬁrst study of a composite biomarker index in low
income, Latina and African American mothers with and
without HIV indicates that MLH and HIV-controls found
the biomarker collection procedures highly acceptable. The
participation rate was high and over 90% of the mothers
provided usable data. Thus, we demonstrate the accept-
ability of the multiple biomarker collection procedures
among minority mothers and the feasibility of obtaining
valid samples from these groups in low-resource settings.
The utility of the biomarker composite to differentiate
groups on the basis of HIV status (MLH vs. controls) was
also demonstrated. As predicted, HIV- control mothers
demonstrated a lower biomarker risk index than MLH.
Contrary to predictions, MLH-I who had received an
intervention were not signiﬁcantly lower on biomarker
composite scores than MLH-W awaiting the intervention.
These ﬁndings are consistent with analyses to date from the
parent study, indicating no effect of the intervention on
traditional psychosocial stress measures (S. Comulada,
personal communication, March 3, 2009) and extend the
absence of MLH intervention effects to a biomarker com-
posite index. No signiﬁcant ethnicity effects were found for
the index scores.
Replicating previous studies among healthy women
(Glover and Stuber 2006; Glover et al. 2008), the present
Table 3 Raw (unadjusted for age) biomarker composite index as a function of group and ethnicity
AA (n = 61) AA (n = 72) Total biomarker index
Controls (n = 44) 1.55 (0.9)
N = 20
1.92 (1.6)
N = 24
1.75 (1.33)
MLH (n = 89) 2.50 (1.3)
N = 41
2.57 (1.6)
N = 48
2.54 (1.4)
MLH-I (n = 47) 2.61 (1.3)
N = 23
2.29 (1.6)
N = 24
2.45 (1.5)
MLH-W (n = 42) 2.39 (1.2)
N = 18
2.63 (1.6)
N = 24
2.52 (1.4)
Total biomarker index 2.20 (1.3) 2.28 (1.6) 2.24 (1.5)
AA African American, LA Latina, MLH Mothers living with HIV?
Table 4 Regression of most recent CD4 count on age, HIV? variables, psychological symptoms, intervention group and the biomarker
composite
Unstandardized
regression coefﬁcient (B)
Standard error of B Standardized
regression Coefﬁcient
(Beta)
t Value t Value
AA only LA only
Age 2.00 2.20 .08 .91 .35 .89
Years since diagnosis -1.75 3.54 -.04 -.49 1.54 -1.66
Baseline CD4 .56 .07 .63 7.86*** 4.52*** 6.75***
Medication adherence (no/yes) 49.81 41.22 .10 1.21 1.06 .03
Depression (BDI) -4.59 1.68 -.21 -2.73** -.84 -3.04**
Biomarker composite -33.68 11.73 -.23 -2.87** -2.40* -2.17*
Constant 361.66 105.54 3.43 1.31 3.33**
R
2 .53 .54 .70
Adjusted R
2 .49*** .46*** .65***
AA African American, LA Latina
* P\.05; ** P\.01; *** P\.001
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123data show that the biomarker composite is associated with
clinically relevant outcomes among HIV? samples.
Greater self-reported medication adherence was associated
with a higher composite and lower CD4 counts, suggesting
a potential role for the composite in understanding the
impact of worsening illness symptoms on medication
adherence. Furthermore, the composite independently
predicted most recent CD4 counts after controlling for
known predictor variables (age, years since diagnosis, prior
baseline CD4 counts, medication adherence, and depres-
sion symptoms). Improving upon prior research, this study
also examined general health behaviors and HIV-speciﬁc
health variables that might serve as potential mediators or
moderators of biomarker outcomes, as recommended
(Arendt 2006; Boarts et al. 2006; Kopinsky et al. 2004).
None of the self-reported health behaviors [sleep, diet,
exercise, caffeine and tobacco use, or substance (alcohol
and drug) use] were different in controls compared to MLH
mothers, nor were these signiﬁcantly correlated with the
biomarker composite. However, these mothers were not
regular substance users, and so composite results may be
different for individuals with very poor health behaviors
and/or concurrent substance abuse. HIV-speciﬁc factors
(CD4, viral load, medication compliance, time since
infection), as measured here, were also unrelated to the
composite index directly. Small sample size may have been
a factor, and it would be helpful to conﬁrm the absence of
health behavior effects in future studies.
Results here also extend prior ﬁndings of a biomarker
composite’s utility in discriminating groups even when
analyses of speciﬁc biomarkers indicate no differences.
MLH means for each individual biomarker were not sig-
niﬁcantly different than controls, despite data suggesting
HIV? sample differences in cortisol, catecholamines,
autonomic activity and lipid distribution (Chittiprol et al.
2008; Kemeny and Schedlowski 2007; Kumar et al. 2002,
2003). This is likely due in part to the complex bi-direc-
tionality of health risk, which cannot be detected when
averaged scores are used. For example, elevated body mass
index (BMI) and waist-to-hip ratio (WHR) are health risks
among the general HIV- population, but body wasting and
associated low BMI and WHR are important health risks
for HIV? samples. Also, elevated cortisol is sometimes
associated with poor HIV outcomes (Antoni et al. 2000,
2005; Cruess et al. 2000; Ironson et al. 2002; Leserman
2003) but ﬁndings are inconsistent and mechanisms of
cortisol dysregulation remain complex (Cole 2008; Sapol-
sky et al. 2007). The signiﬁcant associations found here
between the bi-directional composite and HIV variables
(CD4 cell counts and medication adherence) are promising,
future studies must conﬁrm that a bi-directional biomarker
composite is predictive of meaningful clinical outcomes
and psychological symptoms. Beyond the bi-directionality
of risk, combining multiple biomarkers into a composite
risk score appears to offer predictive value that is absent
with any one or a few indicators alone. Even the chi-square
analyses of bi-directional risk points across groups did not
detect HIV status, intervention or ethnicity differences for
any single biomarker. These ﬁndings support the multi-
system emphasis of the allostatic load framework (Korte
et al. 2005).
The absence of a relationship between the biomarker
composite and psychological symptoms, however, is
incongruent with the concept of allostatic load and is
contrary to previous data indicating a link with depression
and posttraumatic stress symptoms (PSS) (Glover and
Poland 2002; Glover et al. 2008; Glover and Stuber 2006).
Although depression symptoms were associated with the
biomarker composite among control mothers, PSS and
global BSI psychological distress were not. Furthermore,
none of the psychological measures were linked to the
biomarker composite for MLH. Also, the ﬁnal regression
model for MLH showed that the biomarker composite was
an independent predictor of most recent CD4 counts,
accounting for unique variance after controlling for
depression. If the composite represents the cumulative
burden of stress as theorized (McEwen 2004; McEwen and
Seeman 1999; McEwen and Wingﬁeld 2003) one would
expect the index to be associated with depression, global
distress, and post-traumatic stress symptoms—among
controls and MLH mothers.
Several explanations are possible. Past studies showing a
biomarker composite-psychological symptom link are dif-
ferent from the present research in several ways. First,
previous studies supportive of the AL model utilize unidi-
rectional composite scoring. Although bi-directional
composite scoring such as that used here has been recom-
mended (Glei et al. 2007; Seplaki et al. 2005), this method
has not yet been widely examined. Relatedly, because of the
many potential bi-directional effects of HIV? and/or
medications, future studies may require a different set of
biological indicators to quantify psychosocial stress than
those used in large population studies. Finally, ethnicity
effects may have obscured psychological symptom impact
on the biomarker composite. AA women (controls and
MLH) had signiﬁcantly higher blood pressure and heart rate
levels than LA women, but small cell sizes (n\25) limited
power to detect ethnicity and group X ethnicity interactions.
Nonetheless, the ﬁnal regression model among MLH
showed ethnic differences in the predictive value of speciﬁc
variables for most recent CD4 counts. Depression symp-
toms were a signiﬁcant predictor for LA MLH only,
contributing to the larger R
2 for this group relative to AA
women. Also, the t-values for years since diagnosis were in
opposite directions for LA and AA and may reﬂect differ-
ential HIV infection progression as a function of ethnicity.
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123Such ethnicity effects are consistent with recent population-
based studies using similar biomarker composites showing
increased health risk for male and female African Ameri-
cans across all ages (Seeman et al. 2008) and for African
American women speciﬁcally (Geronimus et al. 2006).
Women and minorities have been identiﬁed as at high risk
for health disparities in general, and for increased morbidity
and mortality from HIV/AIDS speciﬁcally (Chu and Sel-
wyn 2008). Thus, the relevance of ethnicity, medical
variables (HIV status and associated disease and treatment
factors), psychological symptoms and their interactions in
relation to biomarker composites requires further study.
There are a number of limitations to the current
research. First, the cross-sectional nature of the research
design does not allow for examination of the biomarker
index over time. Without longitudinal data, the temporal
stability of the biomarker composite is unknown. This issue
is particularly important if biomarker composites are to be
used to evaluate quality of life, intervention efﬁcacy, or
even HIV-speciﬁc disease progression. Second, biological
samples (urine and saliva) were not provided under
supervision of research staff and thus could have been
substituted with samples from non-participants. Nonethe-
less, unlike samples tested for substance use or infection,
levels of the assayed biomarkers have no known social or
tangible negative (or positive) consequence to the partici-
pant so the motivation for substitution is not apparent.
Relatedly, recreational substance use and medical variables
(e.g., CD4 count, viral load, medication compliance, and
stage of HIV) were all based on self-report here. Whereas
there is evidence that self-report shows a strong correlation
with veridical outcomes for some variables (Cunningham
et al. 2007), future studies would be strengthened by
additional objective evidence (e.g., medical chart reviews
or urine testing for substances) conducted close in time to
biomarker assessment. Invasive blood draws to conﬁrm
CD4 and viral load, while increasing accuracy, could
reduce participation rates and increase the cost of bio-
marker research. Future studies will require a careful
balance of scientiﬁc priorities in addressing these issues.
Third, assessment of psychosocial stress concurrent with
biomarker collection was limited to brief instruments
assessing depression, posttraumatic stress and global psy-
chological distress symptoms. As a result, it is not possible
to clarify in detail what psychological or socio-cultural
aspects of daily life may have contributed to high bio-
marker composite indexes. Seeman et al. (2008) found that
low education and income effects on biomarker composites
are large, and remain signiﬁcant even after control for age,
gender, ethnicity and health behaviors like smoking. Fur-
ther examination of biomarker composites in relation to
such demographic factors, as well as the content of per-
ceived stress (e.g., economic conditions, parenting
challenges, racial/ethnic discrimination, intimate partner
problems) and possible buffering factors (e.g., social sup-
port, effective coping strategies, etc.) will be needed to
inform effective interventions.
Despite limitations, the present research demonstrates
that relatively inexpensive and non-invasive biomarkers
from home-collected urine and other simple health mea-
sures (height and weight, waist-to-hip ratio, blood pressure)
can be obtained in community-based settings with minimal
staff involvement. When combined into a composite index
rather than analyzed in isolation, such biomarkers provide
additional explanation of variance in predicting HIV rele-
vant outcomes (e.g., CD4 counts). Biomarker composites
created from the methods used here inherently select
‘‘extreme’’ scorers, thereby supporting comparisons of
individuals at greatest risk and displaying the greatest
‘‘resilience’’ to HIV? stress. Such a strategy may improve
efforts to prevent and intervene among high risk minority
women and their children.
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